Skip to Content

Real-world data on effectiveness of durvalumab after chemoradiotherapy

Real-world data on effectiveness of durvalumab after PACIFIC-R real-world trial confirms effectiveness of durvalumab in patients with unresectable stage III non–small cell lung cancer (NSCLC), concludes Professor Nicolas Girard in this BestPractice Nordic MEDtalk.

Nocolas_gardi

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top